The ERA-EDTA research project LUST -Lung Water by Ultra-Sound Guided Treatment to Prevent Death and Cardiovascular Complications in High Risk End Stage Renal Disease (ESRD) Patients with Cardiomyopathy-, endorsed by EURECA-m Working Group, is a randomized clinical trial (RCT) that involves 23 Renal Units located in the ERA-EDTA geographical area.

The goal of the trial is testing whether a treatment policy guided by US-B lines may prevent death, decompensated heart failure and myocardial infarction as well as progression of LVH and LV dysfunction and hospitalization in high risk dialysis patients with myocardial ischemia or overt heart failure.

The Project was officially launched on Friday March 8th 2013 in Barcelona, Spain with an Inaugural Meeting attended by the representatives of the centres involved in the Study.

Click here to visualize the protocol.
Kindly consider that the total amount granted by the ERA-EDTA is 900.000,00 EUR and not 1.647.500,00 EUR as initially requested.
Additional info concerning the LUST are available in the EURECA-m restricted area accessible only to the EURECA-m members; in case you are not an EURECA-m member, please click here.